Back

Clinical correlates and outcomes associated with B-type natriuretic peptide changes and their interaction with eplerenone in acute heart failure: findings from the EARLEIR trial

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ayako Tezuka

Tokyo Medical University Hospital, Tokyo (Japan)

8 More presentations in this session

Presentation thumbnail
Discussant - Diagnosis of heart failure: natriuretic peptides and novel methods
Presentation thumbnail
Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up
Ms P. Rodriguez Montes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The prognostic implications of serum NT-pro B-type Natriuretic Peptide (NT-proBNP) in emergency medical admissions.
Doctor M. Mckittrick (Limerick, IE)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence-assisted point-of-care lung ultrasound to compare B-lines and congestion scores with NTproBNP levels prior to discharge patients with acute heart failure stage C
Doctor C. Neerapattanakul (Bangkok, TH)
Abstract Slides
Presentation thumbnail
The responses of B-type natriuretic peptide (BNP), mature BNP, proBNP, atrial natriuretic peptide, and N-terminal proBNP to sacubitril/valsartan differs between responders and non-responders
Doctor T. Nishikimi (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources